Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Launched by EMORY UNIVERSITY · Nov 10, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the factors that contribute to suicidal thoughts and behaviors in individuals diagnosed with Bipolar Disorder. The study will explore both environmental influences (like personal situations) and psychological aspects (how people think and feel) that might affect these behaviors. Over a period of six weeks, participants will take part in a group-based program designed to help reduce suicidal behavior and improve their overall quality of life.
To be eligible for this trial, participants must be English-speaking adults aged between 18 and 65 who have been diagnosed with Bipolar Disorder and can provide written consent. However, individuals with certain cognitive issues, acute psychosis, or a history of severe mental health problems, such as schizophrenia or substance abuse disorders, will not be included. Those who join the study can expect to engage in supportive group sessions aimed at learning coping strategies and sharing experiences with others facing similar challenges. This trial is currently recruiting participants, and it offers a valuable opportunity for individuals seeking help and support for their condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English speaking
- • Diagnosis of Bipolar Disorder (BD)
- • Able to provide written informed consent
- Exclusion Criteria:
- • Cognitive impairments
- • Acutely psychotic
- • Medically unstable
- • History of schizophrenia spectrum disorder
- • History of mood incongruent psychotic symptoms
- • History of primary substance disorder
- • History of primary organic disease and/or dementia
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Dorian Lamis, PhD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials